Skip to main content
OpenTrials
Completed

NCT Number: NCT06037525

Clinical Evaluation of the PowerGlide™ Pro Midline Catheter

Clinical evaluation of the PowerGlide™ Pro Midline Catheter in patients with vascular diseases

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pain Catheter Infection Neurologic Manifestations Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University Hospital Augsburg

Augsburg, 86165, Germany

About this study

Clinical evaluation of the PowerGlide™ Pro Midline Catheter in patients with vascular diseases. The selected patients are in need of a long-term i.v. therapy for reasons as antibiotic therapy or alprostadil therapy. The Midline catheter is a device, which is placed via Seldinger's technique to a vein usual on the upper extremity under ultrasound-control.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • need for i.v. therapy longer than 7 days
  • poor peripheral vein status
  • Administration of alprostadil

Exclusion criteria

  • pending dialysis
  • allergy to catheter material
  • minor age
  • life threatening conditions
  • requirement for central venous catheter

Treatment and study plan

PowerGlide™ Pro Midline Catheter

Device

Clinical evaluation of the PowerGlide™ Pro Midline Catheter in patients with vascular disease

Primary outcomes

  1. Dwelling Time

    Time frame: 0-29 days

    Length of catheter in situ time

Secondary outcomes

  1. Administration of Alprostadil

    Time frame: 0-29 days

    Feasibility for the usage of Alprostadil measured by patients with development of thrombophlebitis or occlusion

  2. Catheter Complications

    Time frame: 0-29 days

    Site complications as thrombophlebitis and occlusion

Sponsors and collaborators

Lead sponsor

University Hospital Augsburg

Other

Registry information

Acronym: Midline

Important dates

Study start
2018
Primary completion
2020
Study completion
2023
First posted
Sep 14, 2023
Registry last updated
Nov 18, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.